St. Jude Medical Inc (STJ.N)

STJ.N on New York Stock Exchange

65.87USD
30 Jan 2015
Change (% chg)

$-0.47 (-0.71%)
Prev Close
$66.34
Open
$65.70
Day's High
$66.79
Day's Low
$65.46
Volume
1,762,516
Avg. Vol
481,388
52-wk High
$71.89
52-wk Low
$55.00

STJ.N

Chart for STJ.N

About

St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices. Its principal products in each therapy area are: Cardiac Rhythm Management - tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular - vascular... (more)

Overall

Beta: 1.36
Market Cap(Mil.): $19,039.58
Shares Outstanding(Mil.): 287.00
Dividend: 0.27
Yield (%): 1.63

Financials

Search Stocks

CORRECTED-UPDATE 2-St. Jude Medical lowers forecast; shares fall

(Corrects low end of pvs revenue forecast and U.S. pacemaker and defibrillator growth in 4th and 9th paragraphs)

17 Oct 2014

UPDATE 2-St. Jude Medical lowers forecast; shares fall

(Adds CFO, analyst comment, full-year forecast; updates shares)

15 Oct 2014

St.Jude Medical adjusted profit rises

Oct 15 - Heart device maker St. Jude Medical Inc reported a lower quarterly profit, as it took a $39 million charge related to impairment and restructuring, despite a rise in sales of its devices to treat abnormal heart rhythms.

15 Oct 2014

Fitch Affirms St. Jude Medical's at 'A'; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, August 20 (Fitch) Fitch Ratings has affirmed St. Jude Medical, Inc.'s (STJ) Issuer Default Rating (IDR) at 'A' with a Stable Rating Outlook. Fitch has also affirmed the company's short-term IDR at 'F1'. A full list of Fitch's rating actions is available at the end of this release. The ratings apply to approximately $4.21 billion of debt outstanding as of June 28, 2014. KEY RATING DRIVERS Fitch's rating actions reflect the f

20 Aug 2014

Earnings vs. Estimates

Search Stocks